1. Schonfeld G. Familial hypobetalipoproteinemia: a review. J Lipid Res. 2003; 44:878–83.
Article
2. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. Curr Opin Lipidol. 2020; 31:49–55.
Article
4. Young SG. Recent progress in understanding apolipoprotein B. Circulation. 1990; 82:1574–94.
Article
5. Feingold KR. Introduction to lipids and lipoproteins. In : Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.;2000.
6. Parhofer KG, Barrett PH, Aguilar-Salinas CA, Schonfeld G. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes. J Lipid Res. 1996; 37:844–52.
Article
7. Bonnefont-Rousselot D, Condat B, Sassolas A, Chebel S, Bittar R, Federspiel MC, et al. Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B. Eur J Gastroenterol Hepatol. 2009; 21:104–8.
Article
8. Lonardo A, Tarugi P, Ballarini G, Bagni A. Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma. Dig Dis Sci. 1998; 43:2489–92.